These findings shed new light on the transition from AKI to CKD, although whether targeted intervention with the SGK3/TOPK pathway in TECs and macrophages could serve as a novel therapeutic to ameliorate the AKI–CKD transition still needs to be further explored. The gene discussed is PBK; the disease is chronic kidney disease.